Segnema Pharma Private Limited
About Segnema Pharma Private Limited
Data last updated:
Segnema Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 03 July 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74900DL2018PTC336111. Its GSTIN is 07ABACS5382B1ZJ (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nitin Tanwar and Indu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 17/B G/F Shop Main Road Kalyan Marg Mandawali Unchepar, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.36 Lakh, a growth of 115% compared to the previous year. For the same year it recorded a net loss of ₹63,256 (net margin -26.9%) and EBITDA of -₹60,003 (EBITDA margin -25.5%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressD – 17/B G/F Shop Main Road Kalyan Marg Mandawali Unchepar, New Delhi, Delhi, India – 110092
- IndustryBusiness Services, Miscellaneous Business Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Segnema Pharma Private Limited
The main business activity of Segnema Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Segnema Pharma Private Limited FY 2025 filings available
Segnema Pharma Private Limited reported revenue of ₹2.36 Lakh (up 115% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Segnema Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 2% over three years, including 115% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Segnema Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹60,003 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹63,256 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Segnema Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -25.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -26.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Segnema Pharma are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Segnema Pharma Private Limited
Segnema Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nitin Tanwar | Director | 03 Jul 2018 | 8 Years 3 Months | Current |
| Indu | Director | 03 Jul 2018 | 8 Years 3 Months | Current |
Peer Comparison of Segnema Pharma Private Limited
Segnema Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale trade, except of motor vehicles and motorcycles). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Royal Imperial Private Limited | ₹2.36 Lakh (FY 2025) | •••• | •••• | 70.0% | •••• | Delhi, India |
| Gummies and Gummies Nutrient Private Limited | ₹2.36 Lakh (FY 2025) | •••• | •••• | •••• | Pune, Maharashtra, India | |
| Welze Nine Private Limited | ₹2.36 Lakh (FY 2025) | •••• | •••• | 85.0% | •••• | Mysore, Karnataka, India |
| Sat-Giriraj Marketing and Finance Pvt Ltd | ₹2.36 Lakh (FY 2025) | •••• | •••• | 0.0% | •••• | Nagpur, Maharashtra, India |
| Nandson Logistics Limited | ₹2.36 Lakh (FY 2025) | •••• | •••• | -12.0% | •••• | Nagpur, Maharashtra, India |
| Segnema Pharma Private Limited this company | ₹2.36 Lakh (FY 2025) | •••• | •••• | 115.0% | •••• | New Delhi, Delhi, India |
| Ashoka Mercantile Limited | ₹2.35 Lakh (FY 2025) | •••• | •••• | -96.0% | •••• | Delhi, India |
| Win Lifestyle Solutions Private Limited | ₹2.35 Lakh (FY 2024) | •••• | •••• | -29.0% | •••• | Kolkata, West Bengal, India |
| Kewl Aircomp Marketing Private Limited | ₹2.34 Lakh (FY 2025) | •••• | •••• | •••• | Kolkata, West Bengal, India | |
| Crystal Vincom Pvt Ltd | ₹2.34 Lakh (FY 2024) | •••• | •••• | 8.0% | •••• | Kolkata, West Bengal, India |
| Shukan Financial Services Private Limited | ₹2.34 Lakh (FY 2024) | •••• | •••• | -50.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Segnema Pharma by revenue in the same principal business activity (Wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Segnema Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Segnema Pharma Private Limited
Segnema Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Segnema Pharma Private Limited
Employment history and EPFO contributions of people linked to Segnema Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Segnema Pharma Private Limited
Segnema Pharma Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Indu was appointed as Director on 03 Jul 2018.
Credit Ratings, Litigation & Regulatory Alerts for Segnema Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Segnema Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Segnema Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Segnema Pharma Private Limited
Segnema Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07ABACS5382B1ZJ | Delhi | Active | 11 Oct 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Segnema Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Segnema Pharma Private Limited
Segnema Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 03 July 2018 (8+ years old) and is registered under CIN U74900DL2018PTC336111.
Segnema Pharma reported revenue of ₹2.36 Lakh for FY 2025 (up 115% YoY).
Segnema Pharma has 2 current directors:
- Nitin Tanwar - Director
- Indu - Director
Segnema Pharma reported a net loss of ₹63,256 (net margin -26.9%) and EBITDA of -₹60,003 (EBITDA margin -25.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Segnema Pharma is 2% over three years. In the latest year (FY 2025) revenue rose 115%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Segnema Pharma is 07ABACS5382B1ZJ, registered in Delhi.
The CIN (Corporate Identification Number) of Segnema Pharma is U74900DL2018PTC336111. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Segnema Pharma was incorporated on 03 July 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Segnema Pharma by revenue are Royal Imperial Private Limited, Gummies and Gummies Nutrient Private Limited, Welze Nine Private Limited, Sat-Giriraj Marketing and Finance Pvt Ltd, Nandson Logistics Limited and 5 more, all in the same principal business activity (Wholesale trade, except of motor vehicles and motorcycles).
Indu was appointed as Director on 03 Jul 2018. Nitin Tanwar was appointed as Director on 03 Jul 2018.
The registered office of Segnema Pharma is at D – 17B GF Shop Main Road Kalyan Marg Mandawali Unchepar, New Delhi, Delhi, India – 110092.